---
document_datetime: 2023-09-21 17:21:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/focetria-epar-all-authorised-presentations_en.pdf
document_name: focetria-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8497471
conversion_datetime: 2025-12-28 00:36:08.290957
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutica l Form     | Route of Administration   | Packagin g                 | Content (concentration)   | Package size authorised   |
|-----------------|-----------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|---------------------------|
| EU/1/07/385/001 | Focetria        | 15 µg/ml 1 | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe      |
| EU/1/07/385/002 | Focetria        | 15 µg/ml 1 | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes    |
| EU/1/07/385/004 | Focetria        | 15 µg/ml 1 | Suspension for injection | Intramuscular use         | vial (glass)               | 5.0 ml                    | 10 multidose vials        |

1 Influenza virus surface antigens (haemagglutinin and neuraminidase)* of strain: A/California/7/2009 (H1N1)v like strain used (X-179A) 7.5 micrograms** per 0.5 ml dose * propagated in eggs ** expressed in microgram haemagglutinin. Adjuvant MF59C.1 containing  squalene (9.75 milligrams), polysorbate 80 (1.175 milligrams), sorbitan trioleate (1.175 milligrams) 1/1 Medicinal product no longer authorised